You May Also Like

Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study
Cite
CITE Title : Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study Personal Author(s) : Gregson, John;Kaleebu, Pontiano;Marconi, Vincent C;van Vuuren, Cloete;ChB, MB;Ndembi, Nicaise;Hamers, Raph L;Kanki, Phyllis;Hoffmann, Christopher J;Lockman, Shahin;Pillay, Deenan;de Oliveira, Tulio;Clumeck, Nathan;Hunt, Gillian;Kerschberger, Bernhard;Shafer, Robert W;Yang, Chunfu;Raizes, Elliot;Kantor, Rami;Gupta, Ravindra K; Published Date : Dec 01 2016 Source : Lancet Infect Dis. 17(3):296-304 URL : https://stacks.cdc.gov/view/cdc/45675 Gregson, John et al. (2016). Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. 17(3). Gregson, John et al. "Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study" 17, no. 3 (2016) Gregson, John et al. "Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study" vol. 17, no. 3, 2016 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 767.14 KB]
Personal Author:
Gregson, John ;
Kaleebu, Pontiano
...
Dec 01 2016 | Lancet Infect Dis. 17(3):296-304
Description:
BackgroundHIV-1 drug resistance to older thymidine analogue nucleoside reverse transcriptase inhibitor drugs has been identified in sub-Saharan Africa...
File Type:
[PDF - 767.14 KB]
File Type:
[PDF - 767.14 KB]

Evolution of Primary HIV Drug Resistance in a Subtype C Dominated Epidemic in Mozambique
Cite
CITE Title : Evolution of Primary HIV Drug Resistance in a Subtype C Dominated Epidemic in Mozambique Personal Author(s) : Bila, Dulce Celina Adolfo;Young, Peter;Merks, Harriet;Vubil, Adolfo Salvador;Mahomed, Mussagy;Augusto, Angelo;Abreu, Celina Monteiro;Mabunda, Nédio Jonas;Brooks, James I.;Tanuri, Amilcar;Jani, Ilesh Vinodrai; Published Date : Jul 30 2013 Series : PEPFAR Source : PLoS One. 2013; 8(7). URL : https://stacks.cdc.gov/view/cdc/43356 Bila, Dulce Celina Adolfo et al. (2013). Evolution of Primary HIV Drug Resistance in a Subtype C Dominated Epidemic in Mozambique. 8(7). Bila, Dulce Celina Adolfo et al. "Evolution of Primary HIV Drug Resistance in a Subtype C Dominated Epidemic in Mozambique" 8, no. 7 (2013) Bila, Dulce Celina Adolfo et al. "Evolution of Primary HIV Drug Resistance in a Subtype C Dominated Epidemic in Mozambique" vol. 8, no. 7, 2013 Export RIS Citation Information.
Copy Copied Save
Generic APA MLA Chicago RIS
[PDF - 261.66 KB]
Personal Author:
Bila, Dulce Celina Adolfo ;
Young, Peter
...
Jul 30 2013 | PEPFAR
Description:
ObjectiveIn Mozambique, highly active antiretroviral treatment (HAART) was introduced in 2004 followed by decentralization and expansion, resulting in...
File Type:
[PDF - 261.66 KB]
File Type:
[PDF - 261.66 KB]